Delivery Order 75F40119D10041-75F40124F19017

Award Date 9/26/24
Potential Completion Date 5/28/26
Potential Value $6.8M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $954,448.72 delivery order contract to Dnanexus, Inc., doing business as Dnanexus Inc., located in Mountain View, California. The contract period is from February 18, 2022 through February 21, 2023 and utilizes a firm fixed price contract type. Under the terms of the contract, Dnanexus Inc. will provide services to accept Real World Data through PrecisionFDA into the Food and Drug Administration's Intelligent...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit organization providing cloud-based genomics data management and analysis services. The $796,885.33 contract supports the FDA's PrecisionFDA program, which aims to advance regulatory science through precision medicine approaches. Dnanexus will provide cloud platform services, bioinformatics software, and database services to support the PrecisionFDA collaborative...
The Department of Health and Human Services Food and Drug Administration awarded a $2.3 million delivery order contract to Dnanexus, Inc. for Increment B of PrecisionFDA. Dnanexus will provide labor hours to further develop PrecisionFDA, an FDA initiative that applies bioinformatics and computational biology to regulatory science. The one-year contract was awarded on September 16, 2020 and has a period of performance through September 29, 2021. Work will be conducted by Dnanexus at its...
This is a federal contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit company providing cloud-based genomics data management and analysis services. The contract, titled "A Cloud Platform for Evaluating NGS-Based Diagnostic Test Pipelines," has a ceiling value of $1,993,255.79 and runs through April 27, 2018. The contract is a definitive contract with a firm fixed price pricing type. Dnanexus has previously held other federal contracts with the FDA...
Dnanexus, Inc. was awarded a $3,419,094.15 firm fixed price delivery order by the Department of Health and Human Services' Food and Drug Administration to provide continued development services for the agency's PrecisionFDA Increment D program. Under this delivery order issued against the company's existing $20 million small business set-aside indefinite delivery contract with the FDA for ongoing PrecisionFDA Collaborative Omics Environment support, Dnanexus will deliver operations, development,...
The Department of Health and Human Services Food and Drug Administration awarded a $2.232 million delivery order contract to Dnanexus, Inc. to provide a PrecisionFDA Collaborative Omics Environment in the cloud. With a completion date of September 29, 2020 and no set-aside designation, this time and materials contract supports the FDA's efforts to advance regulatory science through an open data sharing platform for multi-omics data analysis. Located in Mountain View, California, Dnanexus will...
This is a firm fixed-price delivery order contract awarded to Dnanexus, Inc. by the Food and Drug Administration (FDA) to provide operations and maintenance support for the agency's PrecisionFDA platform. The $4,073,921.12 contract has a period of performance through September 29, 2024 and does not have a set-aside designation. Dnanexus is a for-profit company that specializes in cloud-based genomics data management and analysis services. Through prior federal contracts, Dnanexus has supported...
This firm-fixed-price delivery order for $631,840.53 was awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit technology company specializing in cloud-based genomics data management and analysis services. The award is for Phase III of the FY24 Common Data Harmonization System, a project to develop and maintain cloud-based platforms that support collaboration between researchers and regulatory reviewers, as well as genomic data analysis environments. Dnanexus has...
The Department of Health and Human Services Food and Drug Administration awarded a $607,840 delivery order to Dnanexus, Inc. for its PrecisionFDA Collaborative Omics Environment in the cloud. Dnanexus will provide its cloud-based platform as a service under a firm fixed price contract to support FDA's regulatory science programs. The place of performance will be in Silver Spring, Maryland. The one year contract starts in August 2021 and runs through August 2022 to give FDA researchers access...
This $1,134,088.88 firm fixed-price delivery order contract was awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc. to provide a Common Data Harmonization System FIDLE Integration. The contract has a period of performance through March 31, 2024 and is not set aside. Dnanexus, a for-profit organization, has a history of supporting FDA initiatives like the PrecisionFDA program, providing cloud-based bioinformatics tools and genomic analysis platform services to the regulatory...
  • 75F40119D10041
    Indefinite Delivery Contract
  • 75F40119D10041-75F40124F19017
    Delivery Order

This federal contract award was granted by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit corporate entity based in Mountain View, California. The $6,755,725.98 Firm Fixed Price Delivery Order contract is for Dnanexus to provide the PrecisionFDA platform, a FISMA-authorized secure cloud-based data repository and analysis platform for FDA researchers, reviewers, bioinformaticians, and data scientists to enable collaboration on regulatory science and precision medicine initiatives. The contract has a period of performance through May 28, 2026 and was not set aside for small businesses. Dnanexus has previously received multiple federal contract awards and grants from agencies like the FDA and National Institutes of Health to develop and maintain advanced cloud-based genomics data management and analysis solutions.

Generated 6/26/25, 9:55 AM